Plasma biomarkers of Alzheimer’s disease and related dementia for the prediction of hippocampal atrophy amongst adults in Kinshasa, Democratic Republic of Congo
1 of 10
Evaluating the Role of Curli and Gut Escherichia coli Enrichment on Alzheimer’s Disease Outcomes in the 5xFAD Mouse Model
2 of 10
Seeding of synthetic amyloid-β(1-42) monomers by amyloid-β(1-42) present in Alzheimer’s brains
3 of 10
The Impacts of Gut Bacteroides thetaiotaomicron Exposure on Cognitive Impairment and Aβ Pathology in the 5xFAD Alzheimer’s disease Mouse Model
4 of 10
Correlation between biomarkers associated with Alzheimer's disease and the cognitive practice effect
5 of 10
Locus coeruleus physiology in physiology in Alzheimer’s disease
6 of 10
Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a mediator of Cognitive Resilience to Alzheimer’s Disease
7 of 10
Association between Fine Particulate Matter Exposure and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease among a Cognitively Healthy Population-based Brain Cohort
8 of 10
Noradrenergic dysfunction in neurodegenerative disease
9 of 10
Salivary Lactoferrin as a Robust Biomarker of Alzheimer’s Disease